Find insight on Novo Nordisk, Centessa Pharmaceuticals and more in the latest Market Talks covering Health Care.
Hims & Hers has risen since November 2024, outperforming the S&P 500. Click here to see why HIMS stock is a Buy.
Zacks Investment Research on MSN15hOpinion
5 Large Drug Stocks to Watch as Industry Recovers
The drug and biotech sector has recovered over the past couple of months, following a slow start to the year, primarily due ...
Golden Globes host Nikki Glaser shared why she supports people using the injectable drug Ozempic for weight loss, and also ...
SaveHealth explores what the research says about Ozempic's effects on insulin resistance and related conditions.
“Ozempic face” refers to the sagging of skin due to rapid weight loss. Experts say it’s preventable by slowing down weight ...
Medadvisor doesn’t make vaccines, but it helps vaccine makers to promote the importance of immunisation (and boost sales of ...
Tammy Hembrow has appeared to throw shade at her husband Matt Zukowski amid rumours their marriage is on the rocks.
A bombshell exchange on the Signal messaging app - accidentally shared with a journalist - showed an elite group voicing ...
Indian markets posted their seventh straight session of gains, the longest winning streak since September 2024. The NSE Nifty 50 ended 10.30 points higher at 23,668.65, while the BSE Sensex closed ...
Novo Nordisk will pay $200 million up front, with up to $1.8 billion in additional payments down the line, The Wall Street ...
South Carolina Governor Henry McMaster declared a State of Emergency on Saturday as three wildfires spread and prompted evacuations in Polk County.On Monday, McMaster announced on X: "We’ve sec ...